Save your place

Sign in to WhoBought

Please try again later.

Invesco's Recursion Pharmaceuticals, Inc. (RXRX) position

Yes: as of Q1 2026, Invesco holds 691K shares of RXRX worth $2.1M (0.0% of the disclosed portfolio). Last quarter the position was increased by 31.4%. First disclosed Q2 2021.
View full portfolio →
Current value
$2.1M
Shares held
691K
% of portfolio
0.0%
Est. average buy price (i)
$5.72
est. since Q3 2023
Quarter-end price
$3.07

Estimated trade prices

Average price in quarters with purchases
$6.41
Average prices in quarters with sales
  • Q1 2024: $11.14 (22K shares sold)
  • Q2 2023: $7.00 (13K shares sold)
  • Q4 2022: $9.81 (332 shares sold)
  • Q2 2022: $6.69 (350 shares sold)

RXRX price vs Invesco's position

Dates
$2$20$4020222023202420252026New position of 43K shares · Q4 2021. Average closing price $18.82 · Price range $16.14–$21.8643KsharespurchasedAdded 1K shares (2.7%) · Q1 2022. Average closing price $10.63 · Price range $6.16–$18.031KsharespurchasedSold 350 shares (0.8%) · Q2 2022. Average closing price $6.69 · Price range $5.04–$9.26350sharessoldAdded 669 shares (1.5%) · Q3 2022. Average closing price $10.13 · Price range $7.83–$13.60669sharespurchasedSold 332 shares (0.7%) · Q4 2022. Average closing price $9.81 · Price range $7.16–$12.70332sharessoldAdded 75K shares (167.2%) · Q1 2023. Average closing price $7.93 · Price range $6.42–$9.6475KsharespurchasedSold 13K shares (10.7%) · Q2 2023. Average closing price $7.00 · Price range $4.56–$9.9413KsharessoldAdded 14K shares (12.9%) · Q4 2023. Average closing price $7.13 · Price range $5.09–$10.7914KsharespurchasedSold 22K shares (18.5%) · Q1 2024. Average closing price $11.14 · Price range $9.13–$15.5222KsharessoldAdded 10K shares (9.8%) · Q2 2024. Average closing price $8.72 · Price range $7.35–$10.0510KsharespurchasedAdded 7K shares (6.7%) · Q3 2024. Average closing price $7.17 · Price range $5.92–$8.607KsharespurchasedAdded 63K shares (54.6%) · Q4 2024. Average closing price $6.72 · Price range $5.70–$8.2763KsharespurchasedAdded 24K shares (13.4%) · Q1 2025. Average closing price $7.29 · Price range $5.29–$10.8724KsharespurchasedAdded 117K shares (57.6%) · Q2 2025. Average closing price $4.91 · Price range $3.97–$5.84117KsharespurchasedAdded 99K shares (31.0%) · Q3 2025. Average closing price $5.25 · Price range $4.52–$6.5499KsharespurchasedAdded 108K shares (25.8%) · Q4 2025. Average closing price $4.95 · Price range $3.85–$6.79108KsharespurchasedAdded 165K shares (31.4%) · Q1 2026. Average closing price $3.86 · Price range $2.84–$4.96165Ksharespurchased← Earlier —1 purchase
Average closing price · filing quarter
$3.86
Price range · filing quarter
$2.84 – $4.96

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +165K +$638K +31.4% 691K May 12, 2026
Q4 2025 Added +108K +$535K +25.8% 526K Feb 19, 2026
Q3 2025 Added +99K +$520K +31.0% 418K Nov 13, 2025
Q2 2025 Added +117K +$573K +57.6% 319K Aug 13, 2025
Q1 2025 Added +24K +$174K +13.4% 203K May 12, 2025
Q4 2024 Added +63K +$424K +54.6% 179K Feb 13, 2025
Q3 2024 Added +7K +$52K +6.7% 116K Nov 12, 2024
Q2 2024 Added +10K +$85K +9.8% 108K Aug 13, 2024
Q1 2024 Reduced −22K −$249K −18.5% 99K May 14, 2024
Q4 2023 Added +14K +$98K +12.9% 121K Feb 13, 2024
Q3 2023 First covered 107K Nov 13, 2023
Q2 2023 Reduced −13K −$89K −10.7% 107K Aug 11, 2023
Q1 2023 Added +75K +$592K +167.2% 119K May 12, 2023
Q4 2022 Reduced −332 −$3K −0.7% 45K Feb 13, 2023
Q3 2022 Added +669 +$7K +1.5% 45K Nov 14, 2022
Q2 2022 Reduced −350 −$2K −0.8% 44K Aug 15, 2022
Q1 2022 Added +1K +$12K +2.7% 45K May 16, 2022
Q4 2021 New +43K +$818K 43K Feb 14, 2022
Q2 2021 New +6K +$165K 6K Aug 17, 2021
Data through Q1 2026 · filed May 12, 2026
19 grouped rows from 19 quarters

More Invesco positions

Common questions

Does Invesco own RXRX?

Yes. As of Q1 2026, Invesco disclosed 691K shares of RXRX, worth $2.1M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy RXRX?

Invesco first disclosed a RXRX position in Q2 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell RXRX?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in RXRX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of RXRX does Invesco own?

Invesco disclosed 691K shares of RXRX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for RXRX?

Invesco began building the RXRX position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.